There are studies that claim that tumor eradication is associated with a low number of CD4+ T lymphocytes and studies that claim that an increased percentage of CD4+ T lymphocytes are associated with the response to treatment and eradication of the tumor [33, 34]. Here, CD4 is linked to neoplasm.